A team of scientists at the University of Georgia has developed a promising new drug that may one day make treating shingles ...
Herpes simplex virus is a master of bad timing—reappearing briefly, often unnoticed, and just long enough to keep the immune system on its toes. In its genital form, herpes simplex virus type 2 (HSV-2 ...
Vaccines are one of the most important medical inventions of modern times that have saved and enhanced innumerable lives around the world. Despite the technological advances in vaccine design and ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Around one in every five people aged below 50 around the world is ...
The World Health Organization (WHO) has launched a new database that organization officials hope will help improve ...
– ABI-5366 is currently being evaluated in ongoing Phase 1b clinical trial with interim proof-of-concept data expected in fall 2025 – SOUTH SAN FRANCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- ...
Half of the individuals with genital herpes simplex virus (HSV) infection experience several recurrence episodes per year, especially if the causative agent is HSV type 2 (HSV-2). Standard-of-care ...
Dec. 10 (UPI) --More than 840 million people around the world under age 50 are living with genital herpes, according to a new study that calls for new vaccines to tackle the sexually transmitted ...
Role of type-specific and confirmatory Herpes Simplex Virus IgG testing in diagnosing genital herpes
Dr. Prince will provide an overview of Herpes Simplex Virus (HSV), including the distinctions between HSV-1 and HSV-2, their anatomical sites of infection, and the mechanisms underlying viral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results